Abstract

Mouse colorectal cancer (CRC) models generated by orthotopic microinjection of human CRC cell lines reproduce the pattern of lymphatic, haematological and transcoelomic spread but generate low metastatic efficiency. Our aim was to develop a new strategy that could increase the metastatic efficiency of these models. We used subcutaneous implantation of the human CRC cell lines HCT116 or SW48 prior to their orthotopic microinjection in the cecum of nude mice (SC+ORT). This subcutaneous preconditioning significantly enhanced metastatic dissemination. In the HCT116 model it increased the number and size of metastatic foci in lymph nodes, lung, liver and peritoneum, whereas, in the SW48 model, it induced a shift from non-metastatic to metastatic. In both models the number of apoptotic bodies in the primary tumour in the SC+ORT group was significantly reduced compared with that in the direct orthotopic injection (ORT) group. Moreover, in HCT116 tumours the number of keratin-positive tumour buddings and single epithelial cells increased at the invasion front in SC+ORT mice. In the SW48 tumour model, we observed a trend towards a higher number of tumour buds and single cells in the SC+ORT group but this did not reach statistical significance. At a molecular level, the enhanced metastatic efficiency observed in the HCT116 SC+ORT model was associated with an increase in AKT activation, VEGF-A overexpression and downregulation of β1 integrin in primary tumour tissue, whereas, in SW48 SC+ORT mice, the level of expression of these proteins remained unchanged. In summary, subcutaneous preconditioning increased the metastatic dissemination of both orthotopic CRC models by increasing tumour cell survival and invasion at the tumour invasion front. This approach could be useful to simultaneously study the mechanisms of metastases and to evaluate anti-metastatic drugs against CRC.

Highlights

  • Most established human carcinoma cell lines that are used to develop cancer models are adapted to in vitro conditions and present a low metastatic rate after their orthotopic microinjection in immunosuppressed mice

  • Subcutaneous preconditioning enhanced the metastases, without altering colonic tumour growth There were no differences in the percentage of tumour engraftment between groups that underwent implantation of the human colorectal cancer (CRC) cell lines HCT116 or SW48 (SC preconditioning) prior to their orthotopic microinjection (ORT) in the cecum of nude mice (SC+orthotopic injection (ORT)) and ORT groups in the HCT116 (78% vs 100%, respectively) or SW48 (33% vs 14%, respectively) models

  • Implications and future directions This study provides a novel procedure that increases the metastatic efficiency of current CRC mouse models and reproduces the metastatic dissemination observed in humans

Read more

Summary

Introduction

Most established human carcinoma cell lines that are used to develop cancer models are adapted to in vitro conditions and present a low metastatic rate after their orthotopic microinjection in immunosuppressed mice. We previously developed a metastatic cancer model by orthotopic microinjection of human colorectal cancer (CRC) cells that disseminate to all clinically relevant sites (lymph nodes, liver, lung and peritoneum) (Céspedes et al, 2007). Current mouse models of CRC, generated by orthotopic microinjection of human CRC cell lines, rarely reproduce advanced stages of the disease and generate low metastatic efficiency. Their use for understanding the mechanisms underlying metastasis and testing the efficacy of potential anti-metastatic therapies is limited

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call